Sun Pharma Share Price in 2016: Chart, Monthly Trends, & Analysis

How did Sun Pharma shares perform in 2016?

Let's find out!

Sun Pharma share price in 2016 was ₹588.8 Its price on 1st January 2016 was ₹756.12, and by 31st December 2016 it moved to ₹588.8, giving a negative return of -22.13% for the year.

Sun Pharma Share Open, High, Low, and Close prices for the Year 2016 are as follows:

Open	High	Low	Close
₹756.12	₹838.63	₹534.51	₹588.8
1st Jan 2016	Occured in Feb 2016	Occured in Nov 2016	31st Dec 2016

This page will help you understand how Sun Pharma performed in 2016. Let's get started.

For complete insights into Sun Pharma’s incredible stock price performance and growth, see: Sun Pharma Historical Share Price Data from its IPO to 2025

Table: Sun Pharma Share Monthly Close, Low, High Prices for 2016

Month	Sun Pharma	Change%	↑High - ↓Low
Jan	₹814.83	-	↑ ₹819.54 ↓ ₹713.13
Feb	₹797.05	-2.2%	↑ ₹838.63 ↓ ₹749.02
Mar	₹765.4	-4%	↑ ₹818.7 ↓ ₹718.73
Apr	₹757.28	-1.1%	↑ ₹785.15 ↓ ₹743.94
May	₹711.97	-6%	↑ ₹785.94 ↓ ₹705.67
Jun	₹712.29	-	↑ ₹727.46 ↓ ₹662.87
Jul	₹774.69	8.7%	↑ ₹783.89 ↓ ₹711.31
Aug	₹724.01	-6.6%	↑ ₹798.03 ↓ ₹696.89
Sep	₹694.14	-4.2%	↑ ₹764.99 ↓ ₹684.14
Oct	₹694.8	-	↑ ₹722.46 ↓ ₹684.14
Nov	₹663.39	-4.6%	↑ ₹700.03 ↓ ₹534.51
Dec	₹588.8	-11.3%	↑ ₹683.16 ↓ ₹568.25

Chart: CandleStick and Line Chart Showing Monthly Prices

[Click on line name to show/hide a line]

What if You invested ₹10,000 in Sun Pharma in 2016?

In 2016, the opening price of Sun Pharma share was ₹756.12. Today, the price stands at ₹1,693.6, reflecting a growth of 123.98%. If we applying the same growth to your investment of ₹10,000 then, your investment of ₹10,000 in 2016 would have become ₹22,398.56 by 2025. This represents a CAGR of 9.37%.

---

You might also like to check: Sun Pharma Stock Price in 2015 or Sun Pharma Stock Price in 2017

---

References: Stock prices on stockpricearchive.com are gathered from reliable sources only. We take prices from stock exchanges only, majorly from BSE and NSE.

Disclaimer: Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice.